Manufacturing

Press release: New data from Cell and Gene Therapy Catapult report shows move towards commercialisation and 48% increase in GMP manufacturing space despite COVID-19 pandemicPress release: New data from Cell and Gene Therapy Catapult report shows move towards commercialisation and 48% increase in GMP manufacturing space despite COVID-19 pandemicPress release: Investment in UK cell and gene therapy manufacturing set to continuePress release: Investment in UK cell and gene therapy manufacturing set to continuePress release: Accelerated demand for specialist skills in the UK cell and gene therapy industryPress release: Accelerated demand for specialist skills in the UK cell and gene therapy industryPress release: Construction completed on expansion phase, doubling capacity of Cell and Gene Therapy Catapult large scale manufacturing centre in StevenagePress release: Construction completed on expansion phase, doubling capacity of Cell and Gene Therapy Catapult large scale manufacturing centre in StevenagePress release: TCR2 Therapeutics Announces Collaboration With Cell and Gene Therapy Catapult for the Manufacturing of its Novel T Cell Therapies for CancerPress release: TCR2 Therapeutics Announces Collaboration With Cell and Gene Therapy Catapult for the Manufacturing of its Novel T Cell Therapies for CancerPress release: Research Highlights the UK’s Growing Industry and Infrastructure for Manufacturing Cell and Gene TherapiesPress release: Research Highlights the UK’s Growing Industry and Infrastructure for Manufacturing Cell and Gene TherapiesPress release: Stevenage Cell and Gene Therapy Catapult centre gets green light to make new cell and gene therapiesPress release: Stevenage Cell and Gene Therapy Catapult centre gets green light to make new cell and gene therapiesCell and Gene Therapy Catapult opens manufacturing centre to accelerate growth of the industry in the UKCell and Gene Therapy Catapult opens manufacturing centre to accelerate growth of the industry in the UKPress release: CGT Catapult announces viral vector manufacturing technology collaboration with Freeline TherapeuticsPress release: CGT Catapult announces viral vector manufacturing technology collaboration with Freeline TherapeuticsGMP cell and gene therapy manufacturing in the UK: facilities, capabilities and capacityGMP cell and gene therapy manufacturing in the UK: facilities, capabilities and capacityPress release: CGT Catapult announces vector production agreement with AdaptimmunePress release: CGT Catapult announces vector production agreement with AdaptimmuneQuality Control in cell and gene therapy manufacturingQuality Control in cell and gene therapy manufacturing